ES2194835T3 - Agentes antitromboticos a base de tripeptidos. - Google Patents

Agentes antitromboticos a base de tripeptidos.

Info

Publication number
ES2194835T3
ES2194835T3 ES91308785T ES91308785T ES2194835T3 ES 2194835 T3 ES2194835 T3 ES 2194835T3 ES 91308785 T ES91308785 T ES 91308785T ES 91308785 T ES91308785 T ES 91308785T ES 2194835 T3 ES2194835 T3 ES 2194835T3
Authority
ES
Spain
Prior art keywords
group
alpha
amino
substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91308785T
Other languages
English (en)
Inventor
Paul David Gesellchen
Robert Theodore Shuman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2194835T3 publication Critical patent/ES2194835T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Inert Electrodes (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTAN INHIBIDORES DE LA TROMBINA REPRESENTADOS POR LA FORMULA: EN LA QUE A(C = O)CICLOHEXILGLICIL, CICLOHEXENILGLICIL, TIENIGLICIL O NAFTILGLICIL, EN DONDE EL GRUPO (ALFA)-AMINO ESTA PREFERIBLEMENTE SUBSTITUIDO POR ALQUIL POR EJ. METIL O UN GRUPO ALCOXICARBONIL, CICLOXICARBONIL O ARILCOXICARBONIL, POR EJ. T-BUTILOXICARBONIL. A (C = O)TAL COMO UN (ALFA)-METOXIFENILACETIL; O UN GRUPO BICICLICO TAL COMO UN GRUPO TETRAHIDROISOQUINOLIN-1-OIL; O UN GRUPO CICLOALQUILCARBONIL (AMINO SUBSTITUIDO) TAL COMO 1-AMINOCICLO EXIL CARBONIL. TAMBIEN SE SUMINISTRA UN METODO PARA INHIBIR LA FORMACION DE COAGULOS DE SANGRE EN EL HOMBRE Y LOS ANIMALES MEDIANTE LA ADMINISTRACION DE UN INHIBIDOR DE LA TROMBINA DE LA FORMULA ARRIBA REPRESENTADA, ASI MISMO SE PRESENTAN FORMULACIONES FARMACEUTICAS UTILES EN EL PRESENTE METODO.
ES91308785T 1990-09-28 1991-09-26 Agentes antitromboticos a base de tripeptidos. Expired - Lifetime ES2194835T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58955390A 1990-09-28 1990-09-28
US75609191A 1991-09-06 1991-09-06

Publications (1)

Publication Number Publication Date
ES2194835T3 true ES2194835T3 (es) 2003-12-01

Family

ID=27080589

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95201960T Expired - Lifetime ES2169105T3 (es) 1990-09-28 1991-09-26 Agentes antitromboticos tripeptidicos.
ES91308785T Expired - Lifetime ES2194835T3 (es) 1990-09-28 1991-09-26 Agentes antitromboticos a base de tripeptidos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES95201960T Expired - Lifetime ES2169105T3 (es) 1990-09-28 1991-09-26 Agentes antitromboticos tripeptidicos.

Country Status (22)

Country Link
EP (4) EP0684258A2 (es)
JP (1) JP3023019B2 (es)
KR (1) KR100219993B1 (es)
CN (1) CN1036399C (es)
AT (2) ATE234857T1 (es)
AU (1) AU645347B2 (es)
BR (1) BR9104181A (es)
CA (1) CA2052013C (es)
CZ (1) CZ285980B6 (es)
DE (2) DE69132884T2 (es)
DK (1) DK0685489T3 (es)
ES (2) ES2169105T3 (es)
FI (1) FI107733B (es)
HU (2) HU217441B (es)
IE (1) IE913423A1 (es)
IL (1) IL99527A (es)
MX (1) MX9101280A (es)
NO (1) NO309984B1 (es)
NZ (1) NZ239907A (es)
PT (1) PT99068B (es)
RU (1) RU2077538C1 (es)
SK (1) SK281731B6 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
US5416093A (en) * 1991-11-12 1995-05-16 Eli Lilly And Company Antithrombotic agents
ATE159030T1 (de) * 1992-03-04 1997-10-15 Gyogyszerkutato Intezet Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ES2107790T3 (es) * 1992-12-04 1997-12-01 Schering Ag Inhibidor de trombina procedente de la saliva de protostomias.
US5455229A (en) * 1992-12-23 1995-10-03 Eli Lilly And Company Method for minimizing and containing ischemic and reperfusion injury
US5672582A (en) * 1993-04-30 1997-09-30 Merck & Co., Inc. Thrombin inhibitors
JPH06340619A (ja) * 1993-05-03 1994-12-13 Bristol Myers Squibb Co グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
US5462964A (en) * 1993-10-20 1995-10-31 The Du Pont Merck Pharmaceutical Company Dipeptide boronic acid inhibitors of trypsin-like enzymes
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
WO1995023809A1 (en) * 1994-03-04 1995-09-08 Eli Lilly And Company Antithrombotic agents
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
GB2287027A (en) * 1994-03-04 1995-09-06 Lilly Co Eli Tripeptide antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
HU224315B1 (hu) * 1996-06-05 2005-07-28 Gyógyszerkutató Intézet Kft. Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
HU222199B1 (hu) * 1996-06-05 2003-05-28 Gyógyszerkutató Intézet Kft. Véralvadásgátló hatású peptid-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
JP2001525823A (ja) 1997-05-15 2001-12-11 イーライ・リリー・アンド・カンパニー 抗血栓化合物
JP2002501081A (ja) 1998-01-26 2002-01-15 ビーエーエスエフ アクチェンゲゼルシャフト トロンビンインヒビター
KR100377557B1 (ko) * 1999-02-12 2003-03-26 주식회사 엘지생명과학 아실 구아니딘 작용기를 갖는 선택적 트롬빈 억제제
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
AU2002230836A1 (en) 2000-12-18 2002-07-01 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
CA2436176A1 (en) 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
HUP0401312A3 (en) * 2001-08-21 2010-04-28 Ivax Drug Res Inst Peptide arginals and pharmaceutical compositions containing such compounds
RU2205658C1 (ru) * 2002-02-11 2003-06-10 Смахтин Михаил Юрьевич Способ коррекции биохимических и иммунологических нарушений в условиях экспериментальной острой токсической гепатопатии, сопровождающейся повышением иммунологической реактивности
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE68923572T2 (de) * 1988-03-28 1996-01-18 British Tech Group Peptide.
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
GB8823480D0 (en) * 1988-10-06 1988-11-16 Ciba Geigy Ag Antidote

Also Published As

Publication number Publication date
KR100219993B1 (ko) 1999-10-01
NZ239907A (en) 1993-07-27
MX9101280A (es) 1992-05-04
ATE234857T1 (de) 2003-04-15
AU8478091A (en) 1992-04-02
DK0685489T3 (da) 2002-03-11
EP0685489B1 (en) 2001-12-19
CN1036399C (zh) 1997-11-12
JP3023019B2 (ja) 2000-03-21
CN1060472A (zh) 1992-04-22
EP0479489A3 (en) 1993-10-13
AU645347B2 (en) 1994-01-13
NO913773L (no) 1992-03-30
EP0685489A3 (es) 1996-01-10
EP0684258A3 (es) 1996-01-10
CA2052013A1 (en) 1992-03-29
NO913773D0 (no) 1991-09-26
DE69132884T2 (de) 2002-08-22
NO309984B1 (no) 2001-04-30
JPH04257600A (ja) 1992-09-11
RU2077538C1 (ru) 1997-04-20
CA2052013C (en) 2001-01-30
HU211634A9 (en) 1995-12-28
IE913423A1 (en) 1992-04-08
EP0837071A1 (en) 1998-04-22
EP0685489A2 (en) 1995-12-06
PT99068A (pt) 1992-08-31
HU217441B (hu) 2000-01-28
IL99527A (en) 1997-08-14
FI914566A0 (fi) 1991-09-27
CS291391A3 (en) 1992-04-15
HUT59162A (en) 1992-04-28
DE69133217D1 (de) 2003-04-24
ES2169105T3 (es) 2002-07-01
SK281731B6 (sk) 2001-07-10
CZ285980B6 (cs) 1999-12-15
EP0684258A2 (en) 1995-11-29
FI914566A7 (fi) 1992-03-29
FI107733B (fi) 2001-09-28
HU913037D0 (en) 1992-01-28
PT99068B (pt) 1999-02-26
DE69132884D1 (de) 2002-01-31
EP0479489A2 (en) 1992-04-08
EP0479489B1 (en) 2003-03-19
ATE211147T1 (de) 2002-01-15
DE69133217T2 (de) 2004-02-05
BR9104181A (pt) 1992-06-02
KR920006369A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
ES2194835T3 (es) Agentes antitromboticos a base de tripeptidos.
ES2010775A6 (es) Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos.
ES2157424T3 (es) Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia.
UY24704A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
ES2160609T3 (es) Analogos de peptidos como inhibidores irreversibles de la interleuquina-1beta proteasa.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES8205754A1 (es) Procedimiento de preparacion de un nuevo ester octapeptido
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
AR018501A1 (es) Derivados de la dolastatina 15
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
DK0406119T3 (da) Hidtil ukendte peptidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2055115T3 (es) Derivados de fenil-amidina y fenil-guanidina sustituidos en posicion orto y agentes antidiabeticos y hipoglicemicos que los contienen.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
MX9102347A (es) Composicion nematicida que contiene el compuesto 2r, 5r-dihidroximetil-3r,4r-dihidroxipirrolidina.
ES8606882A1 (es) Procedimiento de obtencion de nuevos derivados gonadoliberi-nos y de sus sales de adicion formadas con acidos terapeuti-camente utilizables y complejos de los mismos
PE25195A1 (es) Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial
ES2151614T3 (es) Bencenosulfonilureas y bencenosulfoniltioureas sustituidas, procedimiento para su preparacion, su utilizacion para la produccion de preparados farmaceuticos y medicamentos que las contienen.
ES8606405A1 (es) Procedimiento para preparar peptidos
PT88926A (pt) Processo para a preparacao de derivados do acido aminopimelico e de compostos farmaceuticos que o contem